National and Kapodistrian University of Athens
Φαρμακογενετική της φαιντανύλης στον Ελληνικό πληθυσμό
Abstract
dc:descriptionThis paper sets out to challenge thinking and practice among researchers in the clinical and genetics field that may lead to answers on variability of response to analgesic treatment.Methods: This is a cohort study, performed in Greek cancer patients. Its scope was to identify potential clinical and genetic reasons responsible for opioid change, due to transdermal-fentanyl intolerance, resulting from inadequate analgesia (pain relief<33% in 1week) and/or unacceptable adverse-events (grade≥3 at Common Terminology Criteria-v4.0). The final sample included 289 participants. To investigate responsible clinical reasons for transdermal-fentanyl intolerance its relation with patients’ history, clinical, haematology, biochemistry, demographic and disease related characteristics was studied. Performance status, quality-of-life and mental state questionnaires were also used. For genetic analysis properly selected single nucleotide polymorphisms in the genes STAT6, ARRB2, RGS4 and ADRA2A were studied. Results: Almost one third of the patients had to change to an alternative opioid oral-morphine in order to achieve adequate analgesia or/and avoid adverse-events. The most common adverse-events observed were nausea/vomiting and sleepiness. Statistical analysis demonstrated that younger age and obesity had a higher possibility to contribute to modification of the analgesic treatment. Furthermore, a higher impact of symptoms in patient’s life and chemotherapy could also contribute to the need of change of the opioid analgesic medication. Among the single nucleotide polymorphisms analyzed, only one polymorphism in ARRB2 gene was associated with inadequate response to analgesia with transdermal fentanyl. Furthermore, according to the genetic statistical analysis there is a polymorphism in STAT6 gene which puts suspicion about its relation with the need of opioid change.Conclusion: This study found significant variables for transdermal-fentanyl intolerance. This knowledge may help person-center care in moderate to severe cancer pain.This PhD was performed in the Palliative Care Unit, School of Medicine, of the National and Kapodistrian University of Athens.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2019
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Symeonidi, Matina
- Συμεωνίδη, Ματίνα
Subjects
dc:subject × 22- Γενετική διαφοροποίηση
- Μονονουκλεοτιδικοί πολυμορφισμοί SNPs
- Αναλγησία
- Οπιοειδή παυσίπονα
- Φαιντανύλη
- Μορφίνη
- Ανακουφιστική αγωγή
- Καρκίνος
- Χρόνιος πόνος
- Gentenic variation
- Single nucleotide polymorphisms, SNPs
- Analgesia
- Opioid analgesics
- Fentanyl
- Morphine
- Palliative care
- Cancer
- Chronic pain
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/45119